High-dose chemotherapy and transplantation of autologous CD34+ selected stem cells for progressive systemic sclerosis adjusted to cardiac and lung manifestation: An open-label, non-inferiority phase 2 trial
Authors: Ann-Christin Pecher, Ina Koetter, Katrin Peis et al.
Publication: Joint Bone Spine
Published: May 1, 2026
Source: Crossref